Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2.

Proceedings of the National Academy of Sciences of the United States of America
Chen KatzAssaf Friedler

Abstract

We have characterized the molecular basis of the interaction between ASPP2 and Bcl-2, which are key proteins in the apoptotic pathway. The C-terminal ankyrin repeats and SH3 domain of ASPP2 (ASPP2(Ank-SH3)) mediate its interactions with the antiapoptotic protein Bcl-2. We used biophysical and computational methods to identify the interaction sites of Bcl-2 and its homologues with ASPP2. Using peptide array screening, we found that ASPP2(Ank-SH3) binds two homologous sites in all three Bcl proteins tested: (i) the conserved BH4 motif, and (ii) a binding site for proapoptotic regulators. Quantitative binding studies revealed that binding of ASPP2(Ank-SH3) to the Bcl-2 family members is selective at two levels: (i) interaction with Bcl-2-derived peptides is the tightest compared to peptides from the other family members, and (ii) within Bcl-2, binding of ASPP2(Ank-SH3) to the BH4 domain is tightest. Sequence alignment of the ASPP2-binding peptides combined with binding studies of mutated peptides revealed that two nonconserved positions where only Bcl-2 contains positively charged residues account for its tighter binding. The experimental binding results served as a basis for docking analysis, by which we modeled the complexes of ...Continue Reading

References

Sep 20, 1996·The Journal of Biological Chemistry·L C LeeT G Parslow
Mar 29, 2000·Proceedings of the National Academy of Sciences of the United States of America·S ShimizuY Tsujimoto
Feb 15, 2001·Cell Death and Differentiation·M H Harris, C B Thompson
Feb 24, 2001·Protein Science : a Publication of the Protein Society·A M PetrosS W Fesik
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·A M PetrosS W Fesik
Mar 30, 2001·The Journal of Biological Chemistry·X Espanel, M Sudol
Oct 31, 2001·Molecular Cell·Y Samuels-LevX Lu
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Assaf FriedlerAlan R Fersht
Jul 19, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lars O HanssonAlan R Fersht
Sep 27, 2002·Current Opinion in Biotechnology·Ulf ReimerJens Schneider-Mergener
Mar 12, 2003·Toxicology Letters·Elizabeth A Slee, Xin Lu
Jun 5, 2003·Proteins·Dina Schneidman-DuhovnyHaim J Wolfson
Oct 10, 2003·The Journal of Biological Chemistry·Michael K ManionDavid M Hockenbery
Nov 25, 2003·Oncogene·Rie SugiokaYoshihide Tsujimoto
Mar 4, 2005·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Shinya KobayashiTakashi Okamoto
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Aug 16, 2005·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Naoko TakahashiTakashi Okamoto
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Grace W YuAlan R Fersht
Apr 4, 2006·Analytical Biochemistry·Joseph RosenbluhAbraham Loyter
Jan 30, 2007·Journal of Medicinal Chemistry·Milan BrunckoSteven W Elmore
Feb 27, 2007·Oncogene·J M Adams, S Cory
May 10, 2007·Proceedings of the National Academy of Sciences of the United States of America·Zvi HayoukaAssaf Friedler
Sep 11, 2007·The Journal of Biological Chemistry·Gideon CosterMichal Goldberg
Oct 25, 2007·Biochemical Society Transactions·S RotemA Friedler
May 2, 2008·The Journal of Biological Chemistry·Shahar RotemAssaf Friedler

❮ Previous
Next ❯

Citations

Feb 17, 2009·Protein Engineering, Design & Selection : PEDS·Tali H ReingewertzAssaf Friedler
Nov 11, 2010·Protein Engineering, Design & Selection : PEDS·Assaf Friedler
Jul 24, 2010·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Ling-Fei WuBi-Liu Wei
Mar 24, 2011·Future Medicinal Chemistry·Hadar Benyamini, Assaf Friedler
Dec 13, 2012·Biochimica Et Biophysica Acta·Haidar Akl, Geert Bultynck
Sep 8, 2012·Cellular and Molecular Life Sciences : CMLS·Giovanni MonacoGeert Bultynck
May 15, 2013·Expert Opinion on Drug Delivery·Saradha ChandrasekharVasant V Ranade
Nov 12, 2013·FEBS Letters·Mario Lebendiker, Tsafi Danieli
Oct 13, 2012·Biochemical and Biophysical Research Communications·Giovanni MonacoGeert Bultynck
Oct 19, 2010·European Journal of Medical Genetics·Jill A RosenfeldLisa G Shaffer
Sep 14, 2010·Biochemical and Biophysical Research Communications·Liron Levy-BeladevRaphael Gorodetsky
Aug 8, 2009·Current Opinion in Chemical Biology·Alejandro Wolf-YadlinGavin MacBeath
Dec 4, 2015·Drug Discovery Today·Zhiqing LiuJia Zhou
Mar 16, 2011·Biotechnology and Bioengineering·Susan M Browne, Mohamed Al-Rubeai
Jul 14, 2010·Journal of Molecular Recognition : JMR·Hadar Benyamini, Assaf Friedler
Dec 18, 2009·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka
Oct 24, 2012·The Biochemical Journal·Tamara D Skene-ArnoldCharles F B Holmes
Dec 25, 2010·Acta Microbiologica Et Immunologica Hungarica·Faris Q Alenzi
Jul 31, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Lu XuJian Zhao
Oct 5, 2019·Future Medicinal Chemistry·Aarti Anantram, Mariam Degani
Jan 19, 2011·Chemical Society Reviews·Chen KatzAssaf Friedler
Oct 3, 2018·Communications Biology·Shinya SugimotoYoshimitsu Mizunoe
Aug 14, 2019·Structure·Yeyun ZhouJ N Mark Glover

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis